Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease

Related

• 

  Part 3: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 3 of 3)

  Arshad M. Khanani, MD, MA, FASRS

  Carl J Danzig, MD

  Charles C Wykoff, MD, PhD, FASRS

  John D Pitcher, MD

  Nikolas JS London, MD, FACS, FASRS

  On Demand Cases, Courses, and Papers

  2018

• 

  Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice

  Andrew A. Moshfeghi, MD, MBA, FASRS

  Annual Meeting Talks

  2018

• 

  Intraoperative Use of Microscope-Integrated OCT for Subretinal Gene Therapy

  Ninel Z. Gregori, MD

  Annual Meeting Talks

  2018